Revolut Puts a Euro Stablecoin in Front of Retail, and Someone Else Issues It
Revolut has begun a phased rollout of EURR to selected customers in Denmark, Poland and Portugal. The token is issued by Bridge, with reserves held at a Luxembourg subsidiary of Stripe, and its outstanding supply starts near zero against Circle's EURC.
Revolut has started distributing EURR, a euro-pegged stablecoin, to a selected group of customers in Denmark, Poland and Portugal, according to reports from The Defiant, CoinDesk, The Block and Cointelegraph. The rollout is phased rather than general, and Cointelegraph reports that wider availability across the European Economic Area is expected later this year. The token will support multiple blockchains and can be moved to external wallets, meaning it is not confined to balances inside the app.
The interesting part is who issues it
Revolut is the distributor, not the issuer. EURR is issued by Bridge, the stablecoin infrastructure company, and Decrypt reports that the reserves backing it sit with a Luxembourg subsidiary of Stripe, which owns Bridge. That is a deliberate split. A stablecoin issuer under European rules carries the regulatory obligations around reserve composition, redemption and reporting, and Revolut has chosen to route those obligations to a specialist rather than take them onto its own licence.
For a fintech with tens of millions of customers, that arrangement solves a distribution problem without creating a balance sheet problem. It also means the credit question for a EURR holder is a question about Bridge and its reserve arrangements, not about Revolut. Anyone treating the Revolut brand as the backing is reading the structure wrong.
Starting from nothing against an incumbent
The scale gap is stark at launch. The Defiant reports Bridge's outstanding euro token supply at €374, against €394.5m of Circle's EURC. That is not a typo in the order of magnitude: one is a three-figure sum on day one of a phased rollout, the other is an established float. Euro stablecoins as a category remain a rounding error next to dollar-pegged tokens, and EURC's own size illustrates how small the ceiling has been so far.
What Revolut brings that previous euro stablecoin efforts have not is a consumer funnel. Distribution has been the binding constraint on euro tokens, not issuance capacity. If EURR grows, it will grow because it is sitting next to a current account rather than because it won a technical comparison.
Why this lands on a tokenised assets desk
A euro settlement leg matters for anyone building tokenised securities in Europe. Tokenised equities and funds settling onchain need a cash leg denominated in the currency of the underlying market, and today most of them settle in dollars regardless of where the asset is domiciled. A euro token with real float and real redeemability changes what a European issuer can build without imposing a currency conversion on every trade.
That is a structural argument, not a prediction. EURR at €374 outstanding is not yet a settlement asset for anything. Whether it becomes one depends on supply growth and on which chains it actually lands on, neither of which the launch announcements settle.
What to check next
Three things are measurable from here. First, outstanding supply, which is public and will show whether phased distribution converts into held balances or just into curiosity. Second, the chains EURR deploys on, since a euro token that only lives where there is no tokenised euro-denominated collateral has nowhere to be useful. Third, whether Revolut extends it beyond the three initial markets on the timeline it has indicated.
The dollar stablecoin market got large because it was the default cash leg for crypto trading. The euro version has no equivalent tailwind, which is why distribution through a bank-like app is the most notable thing about this launch and the reserve structure is the second.
We report facts in our own words and link to the reporting we drew them from. We do not reproduce a source's prose, headline or images. Nothing here is investment advice.